ARID1A loss leads to chemotherapy resistance and is associated with a poor clinic outcome for patients with non-small cell lung cancer

被引：1
|
作者：
Yang, Linlin [1 ]
Shen, Changxian [1 ]
Mo, Xiaokui [2 ]
Williams, Terence M. [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4155
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Cytoplasmic ARID1A and poor outcome in ovarian cancer patients.
    Bateman, Nicholas W.
    Byrd, Kevin A.
    Conrads, Kelly A.
    Risinger, John I.
    Morrison, Carl
    Odunsi, Kunle
    Hamilton, Chad A.
    Maxwell, G. Larry
    Darcy, Kathleen M.
    Conrads, Thomas P.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [22] Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
    Grbesa, Ivana
    Pajares, Maria J.
    Martinez-Terroba, Elena
    Agorreta, Jackeline
    Mikecin, Ana-Matea
    Larrayoz, Marta
    Idoate, Miguel A.
    Gall-Troselj, Koraljka
    Pio, Ruben
    Montuenga, Luis M.
    PLOS ONE, 2015, 10 (04):
  • [23] Overexpression of Derlin-1 is Associated with Poor Prognosis in Patients with Non-small Cell Lung Cancer
    Mao, Minhua
    Zhang, Jinsong
    Jiang, Jueru
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (01): : 29 - 34
  • [24] FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
    Wang, Yu
    Wen, Li
    Zhao, Shu-hua
    Ai, Zhen-hua
    Guo, Jun-zhao
    Liu, Wen-chao
    LUNG CANCER, 2013, 79 (02) : 173 - 179
  • [25] Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer
    Langer, C
    Lilenbaum, R
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 8 - 15
  • [26] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [27] Chemotherapy for non-small cell lung cancer in elderly patients
    Chen, YM
    Perng, RP
    Shih, JF
    Tsai, CM
    Whang-Peng, J
    CHEST, 2005, 128 (01) : 132 - 139
  • [28] ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer
    Zhu, Guangsheng
    Shi, Ruifeng
    Li, Yongwen
    Zhang, Zihe
    Xu, Songlin
    Chen, Chen
    Cao, Peijun
    Zhang, Hongbing
    Liu, Minghui
    Pan, Zhenhua
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [29] Chemotherapy of non-small cell lung cancer in elderly patients
    Gridelli, C
    Maione, P
    Colantuoni, G
    Rossi, A
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (16) : 1487 - 1495
  • [30] Chemotherapy resistance and oncogene expression in non-small cell lung cancer
    d'Amato, Thomas A.
    Landreneau, Rodney J.
    Ricketts, William
    Huang, Weidong
    Parker, Ricardo
    Mechetner, Eugene
    Yu, Ing-Ru
    Luketich, James D.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (02): : 352 - 363
12345